Rocket Companies Director Invests $4.3k in Potential Growthby Mark Eisenberg 30.03.2024Rizik's purchase of Rocket Companies' Class A stock reflects confidence in its prospects. Despite a revenue decline, the company showed ...
Afreximbank and Sterling Bank Partner for Supply Chain Financeby Mark Eisenberg 29.03.2024Demica collaborates with major banks, providing supply chain finance solutions. The Bank distributed over US$104 billion and is based in ...
Indonesian Student Turns Selfies into NFT and Memecoin Millionsby John Darbie 29.03.2024Sultan Gustaf Al Ghozali gained over $1 million from his NFT collection "Ghozali Everyday," and now he's creating a memecoin ...
Air Products secures $3.5 billion credit agreementsby Mark Eisenberg 29.03.2024The details of credit agreements with undisclosed banks will be included in a company's Q1 2024 report - based on ...
First Quarter Market Analysis: Record Smashes and Rate Cut Speculationby Mark Eisenberg 28.03.2024Traders anticipate the Fed will begin rate cuts this year as market records continue. Tech stocks stumble amidst Apple's sales ...
Nifty Soars Above 22,300, Sensex Up 655pts – All Sectors in Greenby Mark Eisenberg 28.03.2024The Nifty index in India saw a positive return and performed well, but faced resistance at the 47,500 level. Breaking ...
Ally Financial Appoints Michael G. Rhodes as CEOby Mark Eisenberg 28.03.2024Ally Financial appoints Michael G. Rhodes as their new CEO, effective April 29. Rhodes recently resigned as CEO of Discover ...
Pathward Financial, Inc.: Strong Revenue Growth in 2024?by Mark Eisenberg 28.03.2024Discover the financial report on Pathward Financial, Inc. (CASH) offering banking services in the US. Market cap $1.28B with solid ...
Best Bank Apps for Secure Bankingby Mark Eisenberg 28.03.2024Consumer Reports found that three out of four Americans use banking apps, but it's crucial to choose a secure app. ...
Sichuan Kelun-Biotech Biopharmaceutical: Lowered Expectations Post Resultsby Mark Eisenberg 28.03.2024Losses are expected to increase by 32% to CN¥3.15 per share for Sichuan Kelun-Biotech Biopharmaceutical. This is a significant change ...